Currently, available evidence indicates that TPC-1 (RET/PTC1 mutated) and BCPAP (BRAF-V600E mutated) thyroid tumor cells secrete significantly different amounts of CXCL8 as measured in the cell culture supernatants, both basally and after TNF-α stimulation (132). Here, CXCL8 is linked to thyroid tumor.